Compared side by side
Semax vs NSI-189: how they differ
The short answer
Semax is a nasal-spray peptide derived from ACTH that raises BDNF and nerve growth factor in rats and is approved in Russia for stroke recovery; NSI-189 is an investigational small molecule (not a peptide), taken by mouth, that stimulated new neuron growth in the hippocampus of mice. NSI-189’s phase 2 depression trial missed its main goal and a later phase 2b failed too, while Semax’s human data are small, mostly open-label Russian studies. Commonly reported: a quick lift in focus within minutes to an hour on Semax, and a slow, gradual lift in mood and mental clarity over weeks on NSI-189.
Side by side
| Compared | Semax | NSI-189 |
|---|---|---|
| Category | Cognitive | Cognitive |
| Also known as | ACTH 4-7 Pro8Gly9Pro10, N-acetyl Semax | NSI189, NSI 189 phosphate |
| What it is | A nasal spray nootropic derived from ACTH but modified to remove hormonal effects. | An investigational drug (a small molecule, not a peptide) that stimulated the growth of new neurons in the hippocampus of mice — the brain region critical for memory and mood. |
| How it works | Synthetic heptapeptide derived from ACTH. In rats it raises BDNF and NGF expression, lifts serotonin turnover and amplifies stimulated dopamine release, which supports cognition, focus and neuroprotection. Used clinically in Russia for stroke recovery. | Investigational small molecule (not a peptide) that stimulated hippocampal neurogenesis in mice; in a small human trial, hippocampal volume did not change significantly. Its mechanism is unknown: it works independently of monoamine reuptake, and mouse studies link it to BDNF/TrkB signalling. A phase 2 depression trial missed its primary endpoint, with some self-rated mood and thinking scores improving at the lower dose, and a later phase 2b also failed. |
| Commonly reported | A quick lift in focus, alertness and mental energy within minutes to an hour, nasal stinging, and irritability or poor sleep at high doses or late in the day. Approved in Russia for stroke recovery and memory problems after brain injury. Often paired with Selank — Semax for drive, Selank for calm. | A slow, gradual lift in mood and mental clarity over weeks, headaches and sometimes irritability or anxiety early on, and for many, no noticeable effect. |
| Studied range | Research range: 200–900 mcg. Studied in research — not a recommendation. | Research range: 40–80 mg. Studied in research — not a recommendation. |
| How often | Daily | Daily, split into 2 doses |
| Half-life | Very short (~minutes); CNS effects persist longer | About 17–20 hours (human data) |
| Route | Nasal spray | Oral |
| Typical run | 2–4 week cycles. Some use daily long-term without noted issues. Cycling still advised. | 8 weeks on, 4 off commonly cited. In a small trial, some gains held for weeks after a 4-week course. |
| Evidence | Moderate: animal studies + some human data | Emerging: primarily preclinical / limited human data |
| Common side effects | Nasal irritation, headache, anxiety, increased energy (can disrupt sleep) | Headache, irritability at high doses, vivid dreams, initial anxiety increase |
- Category
- SemaxCognitive
- NSI-189Cognitive
- Also known as
- SemaxACTH 4-7 Pro8Gly9Pro10, N-acetyl Semax
- NSI-189NSI189, NSI 189 phosphate
- What it is
- SemaxA nasal spray nootropic derived from ACTH but modified to remove hormonal effects.
- NSI-189An investigational drug (a small molecule, not a peptide) that stimulated the growth of new neurons in the hippocampus of mice — the brain region critical for memory and mood.
- How it works
- SemaxSynthetic heptapeptide derived from ACTH. In rats it raises BDNF and NGF expression, lifts serotonin turnover and amplifies stimulated dopamine release, which supports cognition, focus and neuroprotection. Used clinically in Russia for stroke recovery.
- NSI-189Investigational small molecule (not a peptide) that stimulated hippocampal neurogenesis in mice; in a small human trial, hippocampal volume did not change significantly. Its mechanism is unknown: it works independently of monoamine reuptake, and mouse studies link it to BDNF/TrkB signalling. A phase 2 depression trial missed its primary endpoint, with some self-rated mood and thinking scores improving at the lower dose, and a later phase 2b also failed.
- Commonly reported
- SemaxA quick lift in focus, alertness and mental energy within minutes to an hour, nasal stinging, and irritability or poor sleep at high doses or late in the day. Approved in Russia for stroke recovery and memory problems after brain injury. Often paired with Selank — Semax for drive, Selank for calm.
- NSI-189A slow, gradual lift in mood and mental clarity over weeks, headaches and sometimes irritability or anxiety early on, and for many, no noticeable effect.
- Studied range
- SemaxResearch range: 200–900 mcg. Studied in research — not a recommendation.
- NSI-189Research range: 40–80 mg. Studied in research — not a recommendation.
- How often
- SemaxDaily
- NSI-189Daily, split into 2 doses
- Half-life
- SemaxVery short (~minutes); CNS effects persist longer
- NSI-189About 17–20 hours (human data)
- Route
- SemaxNasal spray
- NSI-189Oral
- Typical run
- Semax2–4 week cycles. Some use daily long-term without noted issues. Cycling still advised.
- NSI-1898 weeks on, 4 off commonly cited. In a small trial, some gains held for weeks after a 4-week course.
- Evidence
- SemaxModerate: animal studies + some human data
- NSI-189Emerging: primarily preclinical / limited human data
- Common side effects
- SemaxNasal irritation, headache, anxiety, increased energy (can disrupt sleep)
- NSI-189Headache, irritability at high doses, vivid dreams, initial anxiety increase
Typical run: Community practice — opinions vary. Not a clinical recommendation.

Week by week
Each entry’s cards by day window, as the compound pages show them. Day 1 is the day you start it.
Semax
- Day 1–3 Focus snaps into place
- Day 3–7 Each dose builds on the last
- Day 7–14 Learning speed is up
- Day 14–28 The end of a typical cycle
NSI-189
- Day 1–14 Mood and clarity ramp slowly
- Day 14–56 Mood and memory lifting
- Day 56–84 Cycle off and watch what holds
Together or one or the other
Semax and NSI-189 are a common stack: NSI-189 lists semax among its common stacks.
Questions people ask
How long do semax and NSI-189 last?
The half-life of semax is very short (~minutes); CNS effects persist longer. The half-life of NSI-189 is about 17–20 hours (human data).
How often are semax and NSI-189 taken?
Semax: daily. Route: Nasal spray. NSI-189: daily, split into 2 doses. Route: Oral.
How are semax and NSI-189 dosed in research?
The research range for semax is 200–900 mcg. The research range for NSI-189 is 40–80 mg. Studied in research — not a recommendation.
What are the common side effects of semax and NSI-189?
For semax, the library lists: nasal irritation, headache, anxiety, increased energy (can disrupt sleep). For NSI-189: headache, irritability at high doses, vivid dreams, initial anxiety increase.
Are semax and NSI-189 taken together?
Semax and NSI-189 are a common stack: NSI-189 lists semax among its common stacks.